Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)

Vietnam flag Vietnam · Delayed Price · Currency is VND
62,900
+100 (0.16%)
At close: Feb 27, 2026
4.14%
Market Cap 1.35T
Revenue (ttm) 438.01B
Net Income (ttm) 153.56B
Shares Out 21.50M
EPS (ttm) 7,142.41
PE Ratio 8.81
Forward PE n/a
Dividend 4,000.00 (6.34%)
Ex-Dividend Date Mar 20, 2026
Volume 23,158
Average Volume 29,094
Open 62,600
Previous Close 62,800
Day's Range 62,500 - 63,800
52-Week Range 47,000 - 64,200
Beta 0.36
RSI 70.42
Earnings Date Apr 17, 2026

About HNX:DP3

Central Pharmaceutical Joint Stock Company No3 engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally. The company offers medicines from medicinal herbs; pharmaceutical drugs; food that protects health products; and medical equipment; as well as cosmetics products. It is involved in the production and testing of drugs; growing spices and medicinal plants; production of functional foods; distilling and blending of spirits; production of non-alcoholic beverages and mineral water; and manufacturin... [Read more]

Industry Pharmaceutical Preparations
Founded 1962
Country Vietnam
Stock Exchange Hanoi Stock Exchange
Ticker Symbol DP3
Full Company Profile

Financial Performance

In 2025, HNX:DP3's revenue was 438.01 billion, an increase of 4.92% compared to the previous year's 417.49 billion. Earnings were 153.56 billion, an increase of 26.73%.

Financial Statements

News

There is no news available yet.